Mechanism of inhibition of VIP-induced LES relaxation by heme oxygenase inhibitor zinc protoporphyrin IX

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 276, Issue 1 39-1, 1999, Pages

  Rattan, Satish ^a   Fan, Ya Ping ^a   Chakder, Sushanta ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

G protein coupled; Inhibitory neurotransmission; Lower esophageal sphincter; Nitric oxide synthase; Vasoactive intestinal polypeptide

Indexed keywords

ADENYLATE CYCLASE; CHOLERA TOXIN; DEUTEROPORPHYRIN IX; HEME OXYGENASE INHIBITOR; MEMBRANE RECEPTOR; PROTOPORPHYRIN ZINC; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; LOWER ESOPHAGUS SPHINCTER; MALE; NONHUMAN; OPOSSUM; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SECOND MESSENGER; SMOOTH MUSCLE RELAXATION;

EID: 0032944426     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.276.1.g138     Document Type: Article

References (42)

1. Barnette, M. S., F. C. Barone, P. J. Fowler, M. Grous, W. J. Price, and H. S. Ormsbee. Human lower oesophageal sphincter relaxation is associated with raised cyclic nucleotide content. Gut 32: 4-9, 1991.
2. Battish, R., G. Y. Cao, R. B. Lynn, S. Chakder, and S. Rattan. Heme-oxygenase 2 (HO-2) distribution in anorectum of opossum: colocalization with neuronal nitric oxide synthase (nNOS) and vasoactive intestinal polypeptide (VIP) (Abstract). Gastroenterology 114: A719, 1998.
3. Biancani, P., J. H. Walsh, and J. Behar. Vasoactive intestinal polypeptide: a neurotransmitter for lower esophageal sphincter relaxation. J. Clin. Invest. 73: 963-967, 1984.
4. Burks, T. F. Fundamentals of gastrointestinal pharmacology. In: Gastrointestinal Pharmacology and Therapeutics, edited by G. Friedman, E. D. Jacobson, and R. W. McCallum. Philadelphia, PA: Lippincott-Raven, 1997, p. 1-20.
5. Burleigh, D. E., and R. A. Borman. Evidence for a nonneural electrogenic effect of cholera toxin on human isolated ileal mucosa. Dig. Dis. Sci. 42: 1964-1968, 1997.
6. Chakder, S., G. Y. Cao, R. B. Lynn, and S. Rattan. Distribution of heme oxygenase-2 (HO-2) in the internal anal sphincter (IAS) of opossum (Abstract). Gastroenterology 112: A1138, 1997.
7. Chakder, S., S. Rathi, X. Ma, and S. Rattan. Heme oxygenase inhibitor zinc protoporphyrin IX causes an activation of nitric oxide synthase in the rabbit internal anal sphincter. J. Pharmacol. Exp. Ther. 277: 1376-1382, 1996.
8. Chakder, S., and S. Rattan. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle. J. Pharmacol. Exp. Ther. 266: 392-399, 1993.
9. Chakder, S., and S. Rattan. Involvement of cAMP and cGMP in relaxation of internal anal sphincter by neural stimulation, VIP, and NO. Am. J. Physiol. 264 (Gastrointest. Liver Physiol. 27): G702-G707, 1993.
10. Chen, Q., P. Yu, G. De Petris, P. Biancani, and J. Behar. Distinct muscarinic receptors and signal transduction pathways in gallbladder muscle. J. Pharmacol. Exp. Ther. 273: 650-655, 1995.
11. Duhe, R. J., M. D. Nielsen, A. H. Dittman, E. C. Villacres, E. J. Choi, and D. R. Storm. Oxidation of critical cystein residues of type I adenylyl cyclase by o-iodosobenzoate or nitric oxide reversibly inhibits stimulation by calcium and calmodulin. J. Biol. Chem. 269: 7290-7296, 1994.
12. Eglen, R. M., S. S. Hedge, and N. Watson. Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev. 48: 531-565, 1996.
13. Fan, Y. P., S. Chakder, and S. Rattan. Inhibitory effect of zinc protoporphyrin IX on lower esophageal sphincter smooth muscle relaxation by vasoactive intestinal polypeptide and other receptor agonists. J. Pharmacol. Exp. Ther. 285: 468-474, 1998.
14. Fan, Y. P., S. Chakder, and S. Rattan. Heme oxygenase (HO) inhibitor ZN protoporphyrin IX (ZnPP IX) blocks the actions of vasoactive intestinal polypeptide (VIP) by inhibiting G-protein-coupled receptor binding (Abstract). Gastroenterology 114: A750, 1998.
15. Farrugia, G., W. A. Irons, J. L. Rae, M. G. Sarr, and J. H. Szurszewski. Activation of whole cell currents in isolated human jejunal circular smooth muscle cells by carbon monoxide. Am. J. Physiol. 264 (Gastrointest. Liver Physiol. 27): G1184-G1189, 1993.
16. Furchgott, R. F., and D. Jothianandan. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28: 52-61, 1991.
17. Gilbert, R. J., S. Rattan, and R. K. Goyal. Pharmacologic identification, activation, and antagonism of two muscarine receptor subtypes in the lower esophageal sphincter. J. Pharmacol. Exp. Ther. 230: 284-291, 1984.
18. Gonzalez, C., C. Barroso, C. Martin, S. Gulbenkian, and C. Estrada. Neuronal nitric oxide synthase activation by vasoactive intestinal peptide in bovine cerebral arteries. J. Cereb. Blood Flow Metab. 17: 977-984, 1997.
19. Goyal, R. K. Muscarinic receptor subtypes: physiology and clinical implications. N. Engl. J. Med. 321: 1022-1029, 1989.
20. Goyal, R. K., S. Rattan, and S. I. Said. VIP as a possible neurotransmitter of non-cholinergic non-adrenergic inhibitory neurones. Nature 288: 378-380, 1980.
21. Grundemar, L., and L. Ny. Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol. Sci. 18: 193-195, 1997.
22. Houslay, M. D., and G. Milligan. Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem. Sci. 22: 217-224, 1997.
23. Kahl, R. A., and A. G, Gilman. Purification of a protein cofactor required for ADP-ribosylation of the stimulatory regulation component of adenylate cyclase by cholera toxin. J. Biol. Chem. 259: 6228-6234, 1997.
24. Ca channels in the muscarinic and β-adrenergic regulation of airway smooth muscle. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L221-L229, 1995.
25. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
26. Maines, M. D. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37: 517-554, 1997.
27. Moummi, C., and S. Rattan. Effect of methylene blue and N-ethylmaleimide on internal anal sphincter relaxation. Am. J. Physiol. 255 (Gastrointest. Liver Physiol. 18): G571-G578, 1988.
28. Ny, L., P. Alm, P. Ekstrom, B. Larsson, L. Grundemar, and K.-E. Andersson. Localization and activity of haem oxygenase and functional effects of carbon monoxide in the feline lower oesophageal sphincter. Br. J. Pharmacol. 118: 392-399, 1996.
29. Ny, L., K.-E. Andersson, and L. Grundemar. Inhibition by zinc protoporphyrin-IX of receptor-mediated relaxation of the rat aorta in a manner distinct from inhibition of haem oxygenase. Br. J. Pharmacol. 115: 186-190, 1995.
30. Paterson, W. G., and B. Indrakrishnan. Descending peristaltic reflex in the opossum esophagus. Am. J. Physiol. 269 (Gastrointest. Liver Physiol. 32): G219-G224, 1995.
31. Rattan, S., and S. Chakder. Inhibitory effect of CO on internal anal sphincter: heme oxygenase inhibitor inhibits NANC relaxation. Am. J. Physiol. 265 (Gastrointest. Liver Physiol. 28): G799-G804, 1993.
32. Rattan, S., and C. Moummi. Influence of stimulators and inhibitors of cyclic nucleotides on lower esophageal sphincter. J. Pharmacol. Exp. Ther. 248: 703-709, 1989.
33. Rattan, S., C. Moummi, and S. Chakder. CGRP and ANF cause relaxation of opossum internal anal sphincter via different mechanisms. Am. J. Physiol. 260 (Gastrointest. Liver Physiol. 23): G764-G769, 1991.
34. Reed, D., S. M. Miller, G. Farrugia, M. G. Sarr, and J. H. Szurszewski. Immunocytochemical localization of heme oxygenase-2 and co-localization with nitric oxide synthase in myenteric neurons in human stomach and jejunum (Abstract). Gastroenterology 110: A7664, 1996.
35. Ross, E. M. Pharmacodynamics: mechanisms of drug action and the relationship between drug concentration and effect. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, edited by J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman. New York: McGraw Hill, 1996, p. 29-41.
36. Szewczak, S. M., J. Behar, G. Billett, C. Hillemeier, B. Y. Rhim, and P. Biancani. VIP-induced alterations in cAMP and inositol phosphates in the lower esophageal sphincter. Am. J. Physiol. 259 (Gastrointest. Liver Physiol. 22): G239-G244, 1990.
37. Tottrup, A., M. A. Knudsen, F. H. Sorensen, and E. B. Glavind. Pharmacological identification of different inhibitory mediators involved in the innervation of the internal anal sphincter. Br. J. Pharmacol. 115: 158-162, 1995.
38. Trigo-Rocha, F., G. L. Hsu, C. F. Donatucci, and T. F. Lue. The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic neurotransmission in canine penile erection. J. Urol. 149: 872-877, 1993.
39. Vincent, S. R., S. Das, and M. D. Maines. Brain heme oxygenase isoenzymes and nitric oxide synthase are co-localized in select neurons. Neuroscience 63: 223-231, 1994.
40. Yamato, S., J. K. Saha, and R. K. Goyal. Role of nitric oxide in lower esophageal sphincter relaxation to swallowing. Life Sci. 50: 1263-1272, 1992.
41. Yang, C. M., M. C. Hsu, H. L. Tsao, C. T. Chiu, R. Ong, J.-T. Hsieh, and L. W. Fan. Effects of cAMP elevating agents on carbachol-induced phosphoinositide hydrolysis and calcium mobilization in cultured canine tracheal smooth muscle cells. Cell Calcium 19: 243-254, 1996.
42. Zakhary, R., K. D. Poss, S. R. Jaffrey, C. D. Ferris, S. Tonegawa, and S. H. Snyder. Targeted gene deletion of heme oxygenase 2 reveals neural role for carbon monoxide. Proc. Natl. Acad. Sci. USA 94: 14848-14853, 1997.